Moderna (MRNA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

The biotech has momentum as its quarterly report approaches.

Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company's Tuesday update revealing the long‑term results from a cancer therapy study.

We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2025 results on Feb. 13, before ...

The vaccine maker is expanding beyond its COVID-focused offerings.

Moderna (NASDAQ:MRNA) is preparing to release its quarterly earnings on Friday, 2026-02-13. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...